INTELLIGENCE IN ACTION

PRICE TRANSPARENCY

Prescription price transparency is critical to lowering patients’ out-of-pocket costs and preventing “sticker shock” at the pharmacy, which negatively impacts medication adherence and patient safety.

Recent Articles

PRICE TRANSPARENCY

January 15, 2020

How One to Two Seconds Can Improve Patient and Physician Lives

By Andrew Mellin

3minutes

PRICE TRANSPARENCY

December 04, 2019

Forces of Change: The Industry Responds to the Call for Prescription Price Transparency

By Ryan Hess

3minutes

PRICE TRANSPARENCY

November 06, 2019

Record-Breaking FDA Approvals Mean Hope for Patients but Challenges for Healthcare Access, Delivery and Affordability

By Andrea Douglas

10minutes

PRICE TRANSPARENCY

October 29, 2019

When It Comes to Choosing The Right Prescription Price Transparency Model—and Improving Member Care—Seven is the Magic Number for Innovative Health Plans

By Ryan Hess

4minutes

PRICE TRANSPARENCY

October 23, 2019

Surescripts Is Helping Independent Pharmacists Spend More Time with Patients—And Less Time with Paperwork

By Ken Whittemore Jr.

4minutes

PRICE TRANSPARENCY

August 22, 2019

Surescripts Supports CMS in its Effort to Streamline Prior Authorization for Prescribers and Expedite Patient Access to Needed Medications

By Mary Ann Chaffee

3minutes

PRICE TRANSPARENCY

July 25, 2019

How Aurora Health Care Used Electronic Prior Authorization To Cut Clinic Staff Overtime By More Than Half

By Luke Forster-Broten, Manager, Product Innovation

5minutes

PRICE TRANSPARENCY

June 19, 2019

Health Plans and PBMs Team Up to Get Patients Needed Medications Easier and Faster

By Ryan Hess

2minutes

PRICE TRANSPARENCY

May 20, 2019

Federal Government Issues Final Rule: Part D Plans Must Adopt a Real Time Benefit Tool

By Mary Ann Chaffee

3minutes

PRICE TRANSPARENCY

April 15, 2019

Older, Sicker Patients Will Benefit from Real-Time Benefit Tools, So Let’s Not Delay Using Them.

By Mary Ann Chaffee

2minutes

PRICE TRANSPARENCY

March 25, 2019

HIMSS19 Showed Glimpses of a Bright Future, But Also Problem Solving in the Here and Now

By Melissa Nix

3minutes

PRICE TRANSPARENCY

March 15, 2019

HIMSS19 Highlights: Five Takeaways from Healthcare Leaders on Prescription Price Transparency

By Kate Rusciano

4minutes

PRICE TRANSPARENCY

February 19, 2019

Disrupting the Drug Cost Trajectory: Dr. Michelle Mello on Making Medications Affordable

By Melissa Nix

12minutes

PRICE TRANSPARENCY

February 13, 2019

Prescribers and Patients are Working Together to Save Time, Money and Hassle

By Tom Skelton

4minutes

PRICE TRANSPARENCY

December 18, 2018

Federal Government Takes Action to Spur Greater Use of Prescription Price Transparency Tools at the Point of Care

By Mary Ann Chafee, Vice President of Policy and Federal Affairs, Surescripts

3minutes

PRICE TRANSPARENCY

December 03, 2018

How Prescribers are Saving Their Patients Thousands of Dollars on Drugs

By Ryan Hess

3minutes

PRICE TRANSPARENCY

November 14, 2018

Reinventing the Health IT Adoption Curve: Price Transparency at the Point of Care

By Jacqueline Hager, Product Manager, Surescripts

2minutes

PRICE TRANSPARENCY

September 17, 2018

Actionable Intelligence at the Point of Care can Help Prevent Physician Burnout

By Ryan Hess

9minutes

PRICE TRANSPARENCY

September 07, 2018

Surescripts Tackles Prescription Abandonment with Point-of-Care Information That Supports Patient-Provider Shared Decision Making

By Guest Contributor Nancy Fabozzi, Principal Analyst for Digital Health

6minutes

PRICE TRANSPARENCY

August 28, 2018

Five Questions: Mary Ann Chaffee on Price Transparency, Public Health and the Notorious R.B.G.

By Melissa Nix, Editorial Director, Marketing

7minutes

PRICE TRANSPARENCY

August 01, 2018

Patients, Pocketbooks and a Podcast on Prescription Price Transparency

By Melissa Nix, Editorial Director, Marketing

2minutes

PRICE TRANSPARENCY

April 23, 2018

Patients’ Out-of-Pocket Cost Should Weigh Into Prescribing Decisions

By Ryan Hess

5minutes

PRICE TRANSPARENCY

March 22, 2018

HIMSS18 Panel Gets Candid About Prescription Price Transparency

By Kelly Jeffers, Marketing, Surescripts

3minutes

Load more articles

INTELLIGENCE IN ACTION

PRICE TRANSPARENCY

Recent Articles

How One to Two Seconds Can Improve Patient and Physician Lives

Forces of Change: The Industry Responds to the Call for Prescription Price Transparency

Record-Breaking FDA Approvals Mean Hope for Patients but Challenges for Healthcare Access, Delivery and Affordability

When It Comes to Choosing The Right Prescription Price Transparency Model—and Improving Member Care—Seven is the Magic Number for Innovative Health Plans

Surescripts Is Helping Independent Pharmacists Spend More Time with Patients—And Less Time with Paperwork

Surescripts Supports CMS in its Effort to Streamline Prior Authorization for Prescribers and Expedite Patient Access to Needed Medications

How Aurora Health Care Used Electronic Prior Authorization To Cut Clinic Staff Overtime By More Than Half

Health Plans and PBMs Team Up to Get Patients Needed Medications Easier and Faster

Federal Government Issues Final Rule: Part D Plans Must Adopt a Real Time Benefit Tool

Older, Sicker Patients Will Benefit from Real-Time Benefit Tools, So Let’s Not Delay Using Them.

HIMSS19 Showed Glimpses of a Bright Future, But Also Problem Solving in the Here and Now

HIMSS19 Highlights: Five Takeaways from Healthcare Leaders on Prescription Price Transparency

Disrupting the Drug Cost Trajectory: Dr. Michelle Mello on Making Medications Affordable

Prescribers and Patients are Working Together to Save Time, Money and Hassle

Federal Government Takes Action to Spur Greater Use of Prescription Price Transparency Tools at the Point of Care

How Prescribers are Saving Their Patients Thousands of Dollars on Drugs

Reinventing the Health IT Adoption Curve: Price Transparency at the Point of Care

Actionable Intelligence at the Point of Care can Help Prevent Physician Burnout

Surescripts Tackles Prescription Abandonment with Point-of-Care Information That Supports Patient-Provider Shared Decision Making

Five Questions: Mary Ann Chaffee on Price Transparency, Public Health and the Notorious R.B.G.

Patients, Pocketbooks and a Podcast on Prescription Price Transparency

Patients’ Out-of-Pocket Cost Should Weigh Into Prescribing Decisions

HIMSS18 Panel Gets Candid About Prescription Price Transparency

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX